Merck & Co., Inc. $MRK Shares Sold by Synergy Asset Management LLC

robot
Abstract generation in progress

Synergy Asset Management LLC significantly reduced its stake in Merck & Co., Inc. by 95% in the fourth quarter, selling over 81,000 shares. This move aligns with substantial insider selling from executives like Jennifer Zachary and Johannes Oosthuizen, who collectively offloaded shares worth millions. Despite this selling activity, Merck’s recent agreement to acquire Terns Pharmaceuticals for $6.7 billion to bolster its oncology pipeline has led to analyst price target increases and positive sentiment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin